Which has preferable valuation & earnings, NAKA or AUNA?

Auna has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 45.13 -$52.23M -$43.20 N/A Auna $1.23B 0.30 $27.39M $0.26 18.90

Is NAKA or AUNA more profitable?

Auna has a net margin of 1.53% compared to KindlyMD's net margin of -7,397.12%. Auna's return on equity of 16.25% beat KindlyMD's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -7,397.12% -81.32% -54.17% Auna 1.53% 16.25% 4.03%

Which has preferable earnings & valuation, NAKA or SBC?

SBC Medical Group has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 45.13 -$52.23M -$43.20 N/A SBC Medical Group $173.61M 1.72 $50.99M $0.39 7.48

Which has better earnings & valuation, LFMD or NAKA?

LifeMD has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio LifeMD $194.05M 1.20 $14.35M $0.05 96.10 KindlyMD $1.82M 45.13 -$52.23M -$43.20 N/A

Is LFMD or NAKA more profitable?

LifeMD has a net margin of 2.37% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat LifeMD's return on equity. Company Net Margins Return on Equity Return on Assets LifeMD 2.37% -150.88% -22.59% KindlyMD -7,397.12% -81.32% -54.17%

Which has preferable valuation and earnings, BDSX or NAKA?

Biodesix has higher revenue and earnings than KindlyMD. Biodesix is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Biodesix $88.50M 1.85 -$35.26M -$4.06 N/A KindlyMD $1.82M 45.13 -$52.23M -$43.20 N/A

Is BDSX or NAKA more profitable?

Biodesix has a net margin of -33.26% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Biodesix's return on equity. Company Net Margins Return on Equity Return on Assets Biodesix -33.26% -2,101.40% -35.65% KindlyMD -7,397.12% -81.32% -54.17%

Which has better valuation and earnings, NAKA or XGN?

Exagen has higher revenue and earnings than KindlyMD. Exagen is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KindlyMD $1.82M 45.13 -$52.23M -$43.20 N/A Exagen $66.57M 1.70 -$19.95M -$0.89 N/A

Is NAKA or XGN more profitable?

Exagen has a net margin of -29.49% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Exagen's return on equity. Company Net Margins Return on Equity Return on Assets KindlyMD -7,397.12% -81.32% -54.17% Exagen -29.49% -94.37% -28.96%

KindlyMD (NAKA) Competitors

$4.72 +0.40 (+9.26%)

As of 10:03 AM Eastern

Compare

NAKA vs. AUNA, SBC, LFMD, BDSX, and XGN

Should you buy KindlyMD stock or one of its competitors? MarketBeat compares KindlyMD with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KindlyMD include Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Biodesix (BDSX), and Exagen (XGN). These companies are all part of the "healthcare" industry.

How does KindlyMD compare to Auna?

KindlyMD (NASDAQ:NAKA) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, dividends and risk.

KindlyMD presently has a consensus price target of $30.00, indicating a potential upside of 535.59%. Auna has a consensus price target of $6.97, indicating a potential upside of 41.74%. Given KindlyMD's higher probable upside, research analysts plainly believe KindlyMD is more favorable than Auna.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Auna	1 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.40

Auna has a net margin of 1.53% compared to KindlyMD's net margin of -7,397.12%. Auna's return on equity of 16.25% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
Auna	1.53%	16.25%	4.03%

Auna has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	45.13	-$52.23M	-$43.20	N/A
Auna	$1.23B	0.30	$27.39M	$0.26	18.90

In the previous week, KindlyMD had 2 more articles in the media than Auna. MarketBeat recorded 2 mentions for KindlyMD and 0 mentions for Auna. KindlyMD's average media sentiment score of 1.43 beat Auna's score of 0.00 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Positive
Auna	Neutral

KindlyMD has a beta of 15.89, indicating that its stock price is 1,489% more volatile than the broader market. Comparatively, Auna has a beta of 0.82, indicating that its stock price is 18% less volatile than the broader market.

Summary

Auna beats KindlyMD on 8 of the 14 factors compared between the two stocks.

How does KindlyMD compare to SBC Medical Group?

KindlyMD (NASDAQ:NAKA) and SBC Medical Group (NASDAQ:SBC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, analyst recommendations, institutional ownership, media sentiment, profitability, risk, earnings and dividends.

SBC Medical Group has a net margin of 24.09% compared to KindlyMD's net margin of -7,397.12%. SBC Medical Group's return on equity of 15.90% beat KindlyMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
SBC Medical Group	24.09%	15.90%	11.61%

60.8% of SBC Medical Group shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

SBC Medical Group has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	45.13	-$52.23M	-$43.20	N/A
SBC Medical Group	$173.61M	1.72	$50.99M	$0.39	7.48

In the previous week, KindlyMD and KindlyMD both had 2 articles in the media. KindlyMD's average media sentiment score of 1.43 beat SBC Medical Group's score of 1.28 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Positive
SBC Medical Group	Positive

KindlyMD presently has a consensus target price of $30.00, indicating a potential upside of 535.59%. SBC Medical Group has a consensus target price of $8.50, indicating a potential upside of 191.20%. Given KindlyMD's stronger consensus rating and higher probable upside, research analysts clearly believe KindlyMD is more favorable than SBC Medical Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
SBC Medical Group	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

KindlyMD has a beta of 15.89, suggesting that its stock price is 1,489% more volatile than the broader market. Comparatively, SBC Medical Group has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

Summary

SBC Medical Group beats KindlyMD on 9 of the 15 factors compared between the two stocks.

How does KindlyMD compare to LifeMD?

LifeMD (NASDAQ:LFMD) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

LifeMD presently has a consensus price target of $9.14, indicating a potential upside of 90.28%. KindlyMD has a consensus price target of $30.00, indicating a potential upside of 535.59%. Given KindlyMD's higher possible upside, analysts plainly believe KindlyMD is more favorable than LifeMD.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LifeMD	1 Sell rating(s)	1 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.70
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

LifeMD has a net margin of 2.37% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat LifeMD's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LifeMD	2.37%	-150.88%	-22.59%
KindlyMD	-7,397.12%	-81.32%	-54.17%

LifeMD has higher revenue and earnings than KindlyMD. KindlyMD is trading at a lower price-to-earnings ratio than LifeMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LifeMD	$194.05M	1.20	$14.35M	$0.05	96.10
KindlyMD	$1.82M	45.13	-$52.23M	-$43.20	N/A

In the previous week, KindlyMD had 1 more articles in the media than LifeMD. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for LifeMD. LifeMD's average media sentiment score of 1.87 beat KindlyMD's score of 1.43 indicating that LifeMD is being referred to more favorably in the media.

Company	Overall Sentiment
LifeMD	Very Positive
KindlyMD	Positive

LifeMD has a beta of 1.98, indicating that its stock price is 98% more volatile than the broader market. Comparatively, KindlyMD has a beta of 15.89, indicating that its stock price is 1,489% more volatile than the broader market.

35.5% of LifeMD shares are held by institutional investors. 17.2% of LifeMD shares are held by company insiders. Comparatively, 24.5% of KindlyMD shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

LifeMD beats KindlyMD on 10 of the 16 factors compared between the two stocks.

How does KindlyMD compare to Biodesix?

Biodesix (NASDAQ:BDSX) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Biodesix has a beta of 0.59, indicating that its stock price is 41% less volatile than the broader market. Comparatively, KindlyMD has a beta of 15.89, indicating that its stock price is 1,489% more volatile than the broader market.

Biodesix has a net margin of -33.26% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Biodesix's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Biodesix	-33.26%	-2,101.40%	-35.65%
KindlyMD	-7,397.12%	-81.32%	-54.17%

21.0% of Biodesix shares are held by institutional investors. 23.2% of Biodesix shares are held by company insiders. Comparatively, 24.5% of KindlyMD shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Biodesix currently has a consensus target price of $24.00, indicating a potential upside of 52.06%. KindlyMD has a consensus target price of $30.00, indicating a potential upside of 535.59%. Given KindlyMD's higher probable upside, analysts clearly believe KindlyMD is more favorable than Biodesix.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Biodesix	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40

In the previous week, KindlyMD had 1 more articles in the media than Biodesix. MarketBeat recorded 2 mentions for KindlyMD and 1 mentions for Biodesix. Biodesix's average media sentiment score of 1.44 beat KindlyMD's score of 1.43 indicating that Biodesix is being referred to more favorably in the media.

Company	Overall Sentiment
Biodesix	Positive
KindlyMD	Positive

Biodesix has higher revenue and earnings than KindlyMD. Biodesix is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Biodesix	$88.50M	1.85	-$35.26M	-$4.06	N/A
KindlyMD	$1.82M	45.13	-$52.23M	-$43.20	N/A

Summary

Biodesix beats KindlyMD on 8 of the 15 factors compared between the two stocks.

How does KindlyMD compare to Exagen?

KindlyMD (NASDAQ:NAKA) and Exagen (NASDAQ:XGN) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, earnings, profitability, dividends, analyst recommendations, valuation, media sentiment and institutional ownership.

KindlyMD has a beta of 15.89, meaning that its stock price is 1,489% more volatile than the broader market. Comparatively, Exagen has a beta of 2.01, meaning that its stock price is 101% more volatile than the broader market.

In the previous week, Exagen had 2 more articles in the media than KindlyMD. MarketBeat recorded 4 mentions for Exagen and 2 mentions for KindlyMD. KindlyMD's average media sentiment score of 1.43 beat Exagen's score of 0.61 indicating that KindlyMD is being referred to more favorably in the media.

Company	Overall Sentiment
KindlyMD	Positive
Exagen	Positive

Exagen has higher revenue and earnings than KindlyMD. Exagen is trading at a lower price-to-earnings ratio than KindlyMD, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KindlyMD	$1.82M	45.13	-$52.23M	-$43.20	N/A
Exagen	$66.57M	1.70	-$19.95M	-$0.89	N/A

KindlyMD currently has a consensus price target of $30.00, indicating a potential upside of 535.59%. Exagen has a consensus price target of $9.25, indicating a potential upside of 97.73%. Given KindlyMD's higher possible upside, analysts clearly believe KindlyMD is more favorable than Exagen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KindlyMD	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Exagen	1 Sell rating(s)	0 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.78

Exagen has a net margin of -29.49% compared to KindlyMD's net margin of -7,397.12%. KindlyMD's return on equity of -81.32% beat Exagen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KindlyMD	-7,397.12%	-81.32%	-54.17%
Exagen	-29.49%	-94.37%	-28.96%

75.3% of Exagen shares are owned by institutional investors. 24.5% of KindlyMD shares are owned by company insiders. Comparatively, 10.4% of Exagen shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Exagen beats KindlyMD on 9 of the 16 factors compared between the two stocks.

Get KindlyMD News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NAKA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

NAKA vs. The Competition

Export

Metric	KindlyMD	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$82.13M	$8.88B	$6.49B	$12.31B
Dividend Yield	N/A	1.71%	2.67%	5.66%
P/E Ratio	-0.11	24.27	24.05	24.76
Price / Sales	45.13	24.43	542.61	168.32
Price / Cash	N/A	13.73	27.48	37.92
Price / Book	0.10	5.55	10.69	6.90
Net Income	-$52.23M	$177.22M	$3.57B	$337.45M
7 Day Performance	0.85%	2.46%	1.56%	2.84%
1 Month Performance	-37.07%	10.71%	2.49%	4.78%
1 Year Performance	-99.14%	6.44%	26.51%	33.08%

KindlyMD Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
NAKA KindlyMD	4.6549 of 5 stars	$4.72 +9.3%	$30.00 +535.6%	-99.2%	$82.13M	$1.82M	N/A	N/A	Positive News Gap Up
AUNA Auna	4.802 of 5 stars	$4.51 +0.2%	$6.97 +54.5%	-21.9%	$333.79M	$1.23B	17.35	15,254
SBC SBC Medical Group	3.7926 of 5 stars	$3.06 -4.4%	$8.50 +177.8%	-35.2%	$313.90M	$173.61M	7.85	N/A	Positive News Gap Up
LFMD LifeMD	3.4532 of 5 stars	$4.64 -1.2%	$9.14 +97.3%	-62.3%	$224.15M	$194.05M	92.72	230	Positive News Gap Up
BDSX Biodesix	3.6905 of 5 stars	$15.85 +2.6%	$22.00 +38.8%	+162.6%	$164.20M	$88.50M	N/A	220	Positive News Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:NAKA) was last updated on 6/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KindlyMD (NAKA) Competitors